Market Place
Sourcing Support
Seaport Therapeutics to Present at 43rd J.P. Morgan Conference
06 Jan 2025 //
BUSINESSWIRE
Seaport Therapeutics Presents More SPT-300 Phase 1 Data at ACNP
11 Dec 2024 //
BUSINESSWIRE
Seaport Therapeutics Presents Data from SPT-300 Phase 1 Study
11 Dec 2024 //
BUSINESSWIRE
Seaport Therapeutics Adds Sandi Peterson to its Board of Directors
20 Nov 2024 //
BUSINESSWIRE
PureTech Entity Seaport Therapeutics Adds Sandi Peterson to Board
20 Nov 2024 //
BUSINESSWIRE
Seaport Therapeutics Names Lauren White as Chief Financial Officer
05 Nov 2024 //
BUSINESSWIRE
PureTech`s Seaport Therapeutics Names CFO Lauren White
05 Nov 2024 //
BUSINESSWIRE
Seaport docks $225m for its improved neuropsychiatry drugs
22 Oct 2024 //
PHARMAPHORUM
Seaport Closes $225 Million Oversubscribed Series B Financing Round
21 Oct 2024 //
BUSINESSWIRE
PureTech’s Seaport Therapeutics Raises $225M In Series B Financing
21 Oct 2024 //
BUSINESSWIRE
Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of Directors
13 Aug 2024 //
BUSINESSWIRE
PureTech`s Seaport Therapeutics Appoints David Wheadon To Board
13 Aug 2024 //
BUSINESSWIRE
Seaport Therapeutics Appoints Seasoned Executives To Management Team
18 Jun 2024 //
BUSINESSWIRE
PureTech`s Seaport Adds Board Member, Executive Appointments
07 May 2024 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.